Genetic Influences on Cholesterol Responses to Low-Carb Diets Uncovered

As low-carb diets gain traction, the inconsistency in their effect on cholesterol levels has become increasingly apparent. Notably, while some individuals experience negligible changes, others see their LDL cholesterol levels soar. Recent research from Stanford University suggests that genetic predispositions may play a key role in these varied responses.

Central to the findings is the relationship between saturated fat consumption—often incorporated in low-carb diets—and genetic factors impacting LDL cholesterol levels, which are critical in assessing heart disease risk. "Our findings suggest that some individuals may be more sensitive to the LDL cholesterol-raising effects of saturated fat, particularly in the context of a low-carbohydrate diet, because of their genetic background," commented Dr. Alexa Barad, a postdoctoral scholar at Stanford, during her presentation at NUTRITION 2026, the annual meeting of the American Society for Nutrition.

Diverse Responses to Dietary Changes

This research underscores the complexity of dietary responses, particularly regarding low-carb diets. Barad explained, "It's easy to oversimplify dietary discussions. One individual might claim that low-carb diets always increase LDL cholesterol, while another could insist theirs didn't change at all. Our findings indicate that both experiences are valid and largely influenced by genetics." Prior studies have shown that low-carb diets can facilitate weight loss and enhance blood glucose control; however, the repercussions on LDL cholesterol levels have remained inconsistent.

Research Methodology and Insights

The researchers aimed to determine if genetic insights could identify those who might benefit from lower carbohydrate intake versus those at risk of heightened cholesterol. They analyzed data from the DIETFITS trial, which involved over 600 adults randomly assigned to follow either a healthy low-carb or a healthy low-fat diet for a year—a trial that did not demonstrate a notable advantage for weight loss linked to either diet.

Focusing on 431 participants with available genetic data, the team examined the interplay between an individual's genetic makeup, saturated fat intake, diet type, and cholesterol changes at the 6-month mark. Their results indicated that individuals on the low-carb diet who possessed a genetic predisposition for higher LDL cholesterol were more likely to experience increased levels.

This sensitivity to saturated fat consumption primarily drove the observed trends, as those with the most significant genetic risk exhibited notable increases in LDL cholesterol associated with higher saturated fat intake. Intriguingly, such a correlation was absent among the participants adhering to the low-fat diet, emphasizing the unique intersection of genetics and dietary effects.

The Role of Genetic Scoring

Instead of isolating individual genetic variants—common in previous studies—the researchers employed polygenic scoring, which combines multiple genetic variants to assess an individual's overall predisposition to high LDL cholesterol. Barad envisioned a future where these scores could empower healthcare professionals to tailor dietary recommendations based on a patient's genetic profile.

While genetic testing could enhance insights into dietary responses, Barad asserted that it isn't the only takeaway from the study. Understanding the varied ways individuals react to the same culinary choices is essential for personalized nutrition. Regular monitoring of an individual's cholesterol response is more crucial than adhering to a one-size-fits-all dietary guideline.

Guidance for Low-Carbohydrate Diets

Current dietary recommendations advocate for keeping saturated fat intake to under 10% of daily calories, favoring unsaturated fats over saturated ones. For those adopting a low-carb lifestyle, Barad encourages prioritizing healthy fat sources such as nuts, seeds, olive oil, and avocados while being cautious with saturated fat-laden foods like butter, fatty cuts of meat, and processed meats. This cautious approach can potentially mitigate the risk of adverse cholesterol fluctuations.

The DIETFITS trial received funding support from various institutes, including the National Institute of Diabetes and Digestive and Kidney Diseases. Although Dr. Barad presented these findings at a respected conference, they remain preliminary pending further validation in broader populations.

For anyone navigating the complexities of diet-related health impacts, the implications of these findings are significant. Monitoring, understanding genetic influences, and making informed dietary choices will be key moving forward.